ARTICLE | Clinical News
Sanctura trospium regulatory update
May 31, 2004 7:00 AM UTC
FDA granted marketing approval for Sanctura trospium to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency. Pliva d.d. (LSE:PLVD, Zagreb, Croatia...